Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2003
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003EP1324749A2 Medicinal aerosol formulations
07/09/2003EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
07/09/2003EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses
07/09/2003EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
07/09/2003EP0823906B1 Piperazino derivatives as neurokinin antagonists
07/09/2003EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein
07/09/2003CN1429276A Modulating production of pneumococcal capsular polysaccharide
07/09/2003CN1429222A 激酶抑制剂 Kinase inhibitors
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1429209A Disulfide derivatives useful for treating allergic diseases
07/09/2003CN1429208A Aniline disulfide derivatives for treating allergic diseases
07/09/2003CN1429103A Novel process
07/09/2003CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype
07/09/2003CN1428163A Medicine bag for curing asthma
07/09/2003CN1428151A Chinese medicine composition for curing cough with dyspnea due to pulmonary disease-compound Runfei kechuanning medicine
07/09/2003CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist
07/09/2003CN1113675C Metered dose inhaler for fluticasone propionate
07/09/2003CN1113661C Chinese medicine for eliminating thick sputum and clearing away heat and toxic material and its preparing method
07/08/2003US6590085 Derivatives of monosaccharides as cell adhesion inhibitors
07/08/2003US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist.
07/08/2003US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful
07/08/2003US6589951 Phthalazine derivatives as phosphodiesterase 4 inhibitors
07/08/2003US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders
07/08/2003US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
07/08/2003US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample
07/08/2003US6589560 Stable glassy state powder formulations
07/08/2003US6589551 Chewable oral unit dosage
07/08/2003CA2361954C Metered dose inhaler for albuterol
07/08/2003CA2290501C Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
07/08/2003CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
07/03/2003WO2003054156A2 Novel g proein-coupled receptor, gave7
07/03/2003WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof
07/03/2003WO2003054012A2 Leptin proteins
07/03/2003WO2003053997A2 Methods of increasing endogenous erythropoietin (epo)
07/03/2003WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
07/03/2003WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003WO2003053969A1 Imidazoquinoline derivatives
07/03/2003WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands
07/03/2003WO2003053967A1 Aroyl pyridinones
07/03/2003WO2003053966A2 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
07/03/2003WO2003053961A1 Benzothiazoles
07/03/2003WO2003053957A1 Benzhydryl derivatives
07/03/2003WO2003053946A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
07/03/2003WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists
07/03/2003WO2003053930A1 1,4-dihydro-1,4-diphenylpyridine derivatives
07/03/2003WO2003053926A1 Novel phenylalanine derivative
07/03/2003WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003WO2003053467A1 Drug for regenerating tissue and vessel and method therefor
07/03/2003WO2003053455A1 Surfactant prevention of lung complications from cancer chemotherapy
07/03/2003WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
07/03/2003WO2003053442A1 Tempamine compositions and methods of use
07/03/2003WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
07/03/2003WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003WO2003053424A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production
07/03/2003WO2003053422A2 Method and compositions for treating respiratory pathologies
07/03/2003WO2003053368A2 Chalcone derivatives and their use to treat diseases
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells
07/03/2003WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002085338B1 Ipratropium formulation for pulmonary inhalation
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/03/2003WO2002022801A9 Mammalian receptor genes and uses
07/03/2003WO2002018389A3 Thienopyrimidine
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125383 For treating or preventing emphysema, cancer and dermatological disorders
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125350 Combination of formoterol and a tiotropium salt
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125339 Substituted alkylamine derivatives and methods of use
07/03/2003US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125321 Administering a compound that inhibits the contraction of the myosin light chain of pulmonary epithelial cells
07/03/2003US20030125318 Benzothiazole derivatives with activity as adenosine receptor ligands
07/03/2003US20030125313 Prophylaxis/treatment of respiratory system disorders; administered by inhalation; potentiation; reversible airways obstruction, e.g., asthma, chronic obstructive pulmonary diseases (COPD) (e.g. bronchitis, emphysema); infections
07/03/2003US20030125299 Method for treating or preventing inflammatory diseases
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124150 Kit for reducing aching
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 878